Dear Editor,

COVID-19 is a new emerging viral disease that can cause severe respiratory distress. The first patient was reported in Wuhan within the Republic of China,\[[@ref1]\] before the disease widespread around the world. The underlying illness is reported for association with severity of COVID-19. Regarding cerebrovascular disease, a Chinese report showed that it is a risk factor for severe COVID-19 infection.\[[@ref2]\]

Here, the author would like to present additional data from the second country that the new disease had occurred since early January 2020, Thailand.\[[@ref3]\] At present (8^th^ April 2020), the total number of COVID-19 patients with 30 deaths in Thailand is 2,369. Two (0.08%) from all COVID-19 patients have underlying cerebrovascular diseases. Focusing on association between underlying cerebrovascular disease and mortality \[[Table 1](#T1){ref-type="table"}\]. The preliminary observation from our setting did not support the association between having underlying cerebrovascular disease and poor outcome of COVID-19. Further analysis based on more data from international settings is recommended to clarify the exact clinical relationship between COVID-19 and cerebrovascular disease.

###### 

Association between underlying cerebrovascular disease and mortality

  Mortality   Underlying cerebrovascular disease   
  ----------- ------------------------------------ -------
  Yes         0                                    30
  No          2                                    2,337

\*Odds ratio = 0
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